BXYEarnings•globenewswire•
BioXcel Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Updates
Sentiment:Neutral (45)
Summary
Topline data from SERENITY At-Home Phase 3 trial for acute treatment of agitation associated with bipolar disorders or schizophrenia expected in August
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 12, 2025 by globenewswire